Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesPopulation-based analysis of normal total PSA and percentage of free/total PSA values: results from screening cohort
Urology, 07/02/09
Capitanio U et al. - In a study to examine the distribution of total prostate-specific antigen (tPSA) and percentage of free/total PSA (%f/tPSA) values in pts undergoing prostate cancer (PCa) screening, the results can guide clinicians regarding population-based distribution of serum tPSA and %f/tPSA values. Those values can be used for counseling, as well as in the informed consent process before prostate biopsy.
Methods- Data from 4 consecutive annual PCa screening events held in Montreal, Canada were examined with respect to age, tPSA, and %f/tPSA in 3222 men.
- Median PSA level was 1.0 ng/mL and median %f/tPSA was 26%.
- Using the interquartile range around the median, the upper bound for tPSA was situated at 1.9 ng/mL and the lower bound for %f/tPSA was at 19%.
- The 90th percentile for median tPSA was 3.8, and the 10th percentile for median %f/tPSA was 14.
- PSA and %f/tPSA showed a relation with age.
- The 75th percentile for median tPSA level in the age category 40-49, 50-59, 60-69, and 70-79 yrs was 1.1, 1.4, 2.6, and 3.6 ng/mL, respectively.
- The 25th percentile for median %f/tPSA level in the age category 40-49, 50-59, 60-69, and 70-79 yrs was 19, 21, 18 and 19 ng/mL, respectively.
Related Articles
Prostatic specific antigen for prostate cancer detection
International Braz J Urol, 10/30/09
Relevance Score: 97%
Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/16/09
Relevance Score: 92%
Relationship Between Prostate-specific Antigen and Hematocrit: Does Hemodilution Lead to Lower PSA Concentrations in Men With a Higher Body Mass Index
Urology, 10/28/09
Relevance Score: 89%
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Relevance Score: 89%
PSA at postoperative three months can predict biochemical recurrence in patients with pathological T3 prostate cancer following radical prostatectomy
International Journal of Urology, 10/15/09
Relevance Score: 89%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-Term Complete Regression of Nodal Marginal Zone Lymphoma Transformed Into Diffuse Large B-Cell Lymphoma With Highly Active Antiretroviral Therapy Alone in Human Immunodeficiency Virus Infection
The American Journal of the Medical Sciences, 12/18/09
Extensive Involvement of the Gastrointestinal Tract by a de novo Presentation of the Monoblastic Type of Myeloid Sarcoma: A Case Report of a Rare Entity That is Often Misdiagnosed
The American Journal of the Medical Sciences, 12/18/09
Anticyclic Citrullinated Peptide Antibody-Positive Paraneoplastic Polyarthritis in a Patient With Metastatic Pancreatic Cancer
The American Journal of the Medical Sciences, 12/18/09
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09
Statin Therapy Ameliorates Renal Allograft Function
Transplantation Proceedings, 12/18/09
Late Acute Kidney Transplant Rejection: Clinicopathological Correlates and Response to Corticosteroid Therapy
Transplantation Proceedings, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor